U.S. Life Sciences Stock News

Copart stock has had a tough run over the last year, yet the current checks suggest the market may now be pricing it below what its intrinsic value estimate implies. The share price is down 42.0% over the past year, which raises the question of whether sentiment has turned more negative than the underlying business justifies. For a company like Copart, the long term value investors focus on tends to hinge on how steadily it can convert vehicle auction volumes into cash flow. At the same...

Norwood Financial (NWFL) has put up a clean set of Q2 2026 numbers, with revenue at US$27.4 million and basic EPS at US$0.86, building on a trailing twelve month revenue base of US$99.7 million and EPS of US$2.88. The company has seen revenue move from US$20.4 million in Q2 2025 to US$27.4 million in Q2 2026, while quarterly EPS has gone from US$0.67 to US$0.86 over the same stretch, giving investors a clearer read on how earnings power is feeding through to margins. See our full analysis for...

Carnival (CCL) is back in focus after its cruise line held a steel cutting ceremony for Carnival Destiny, the first Ace Class ship, highlighting long term capacity and product plans. See our latest analysis for Carnival. Despite the fanfare around Carnival Destiny and a fresh dividend declaration, Carnival’s recent share price momentum has been weak, with the stock down 13.55% on a 30 day share price return and 15.59% year to date. However, the 3 year total shareholder return of 49.47% and 5...

On July 22, 2026, monday.com Ltd. announced a restructuring plan centered on its AI Work Platform, including a roughly 20% workforce reduction and expected net charges of about US$45 million to US$55 million, mainly from severance and office space impairments, to be largely recognized in the second half of 2026. At the same time, monday.com reaffirmed its full‑year 2026 revenue guidance of 19% to 20% year‑on‑year growth, signaling confidence that the AI-focused reorganization can proceed...

Stifel Financial (SF) has put solid numbers on the table for Q2 2026, with revenue of US$1.5 billion, basic EPS of US$1.41 and trailing 12 month EPS of US$5.93 backing up a net profit margin of 15.6% and earnings growth of 59.8% over the past year. The company has seen revenue move from US$1.28 billion in Q2 2025 to US$1.45 billion in Q2 2026, while quarterly basic EPS stepped up from US$0.94 to US$1.41 over the same period. This performance anchors a 12 month revenue base of US$5.9 billion...

Farmers National Banc (FMNB) just posted Q2 2026 results with total revenue of US$68.0 million and basic EPS of US$0.39, alongside trailing twelve month revenue of US$218.4 million and EPS of US$1.49 that reflect year over year earnings growth of 31.7%. Over recent quarters, revenue has moved from US$43.5 million in Q2 2025 to US$68.0 million in Q2 2026, while quarterly EPS has ranged between roughly US$0.33 and US$0.39. This sets up a closer look at how a 30.4% net profit margin shapes the...

WesBanco (WSBC) has put up a clean Q2 2026 scorecard, with revenue of US$266.6 million, basic EPS of US$0.92 and trailing twelve month EPS of US$3.47 sitting alongside reported year over year earnings growth of 165.2%. Over recent quarters, revenue has moved from US$257.5 million in Q2 2025 to US$262.5 million in Q4 2025 and then to US$266.6 million in Q2 2026. Quarterly EPS has shifted from US$0.57 in Q2 2025 to US$0.81 in Q4 2025 and now US$0.92, framing the latest release against a clear...

Healthcare Services Group (HCSG) has posted Q2 2026 revenue of US$470.8 million and basic EPS of US$0.33, with trailing twelve month EPS of US$1.75 reflecting earnings growth of about 64% over the past year. Over recent quarters, revenue has ranged from US$447.7 million in Q1 2025 to US$470.8 million in Q2 2026. Quarterly basic EPS has moved from a loss of US$0.44 in Q2 2025 to a positive US$0.33 in the latest quarter, and trailing net margin has improved from 2.4% to 3.7%. This puts the...

Tapestry (TPR) lifted its fiscal 2026 guidance, pointing to expected revenue above US$7.75b and EPS of US$6.40 to US$6.45, a shift supported by the role of Coach and fresh leadership at Kate Spade. See our latest analysis for Tapestry. Tapestry’s current share price of US$143.73 comes after a 1-day share price return of 1.10% and a year to date share price return of 11.36%, while the 1-year total shareholder return of 33.35% alongside a very large 5-year total shareholder return suggests...

Hanmi Financial (HAFC) opened Q2 2026 with total revenue of about US$71.0 million and basic EPS of roughly US$0.80, supported by quarterly net income of US$23.5 million. The company has seen revenue move from about US$57.6 million and EPS of roughly US$0.50 in Q2 2025 to US$71.0 million and around US$0.80 in Q2 2026, while trailing twelve month revenue sits near US$277.9 million and EPS around US$2.99. This sets up a results season where margins and credit quality are firmly in focus for...

Fidelity D & D Bancorp (FDBC) has put up another solid quarter, with Q2 2026 revenue of US$25.5 million and basic EPS of US$1.35, sitting on top of trailing 12 month revenue of US$96.2 million and EPS of US$5.27 that come with a 29% earnings growth figure over the past year. Over recent quarters the company has seen revenue move from US$22.98 million in Q2 2025 to US$25.5 million in Q2 2026, while quarterly EPS has tracked from US$1.20 to US$1.35 across the same comparison. This sets up a...

Beam Therapeutics (BEAM) is back in focus after Ark Invest increased its position, as investors weigh upcoming clinical milestones, including a global BEAM-302 trial and a planned FDA marketing application for risto-cel. See our latest analysis for Beam Therapeutics. Despite Ark Invest’s increased stake and Beam Therapeutics’ upcoming clinical milestones, recent momentum has been weak, with the share price down 25.0% over 30 days and the 1-year total shareholder return still positive at...

Baxter Healthcare Corporation previously initiated a voluntary FDA Class I recall of over 10,000 Hillrom VOLARA System patient circuits after reports that nebulizer cup leakage could cause reduced oxygen levels and ineffective treatment in patients across the US and Canada. This high‑severity device recall puts Baxter’s quality controls and risk management under closer scrutiny, raising questions about potential operational and regulatory implications for its broader medical device...

Moody's (MCO) just posted Q2 2026 results with revenue of US$2.2 billion and basic EPS of US$5.04, set against trailing 12 month revenue of US$8.2 billion and EPS of US$15.80 that has been growing faster than the broader US market. Over the past six quarters, revenue has shifted from US$1.90 billion in Q2 2025 to US$2.2 billion in Q2 2026, while quarterly EPS moved from US$3.22 to US$5.04, with trailing 12 month earnings up 31.1% year over year. With net profit margins in the trailing period...

Why the JLWS award matters for nLIGHT stock nLIGHT (LASR) has drawn fresh attention after being selected for the Joint Laser Weapon System OTA agreement, an award that starts at US$44 million and could reach up to US$627 million. See our latest analysis for nLIGHT. The JLWS award has arrived after a strong share price run for nLIGHT, with the stock showing an 88.79% year to date share price return and a very large 271.49% 1 year total shareholder return, although the 1 day move slipped 3.71%...

Philip Morris International (PM) has put solid numbers on the board for Q2 2026, with revenue of US$11.2b, basic EPS of US$1.80 and net income of US$2.8b. Trailing 12 month figures show revenue of US$42.5b, basic EPS of US$6.96 and net income of US$10.8b. Over recent quarters the company has seen revenue move from US$10.1b and EPS of US$1.95 in Q2 2025 to US$11.2b and EPS of US$1.80 in Q2 2026. The trailing net margin is sitting well into the mid 20s, which gives investors a clearer view of...

Parke Bancorp (PKBK) has reported Q2 2026 results with total revenue of US$23.2 million and basic EPS of US$1.04, supported by trailing 12 month revenue of US$88.8 million and EPS of US$3.90 alongside a 43.6% improvement in earnings over the last year. Over recent quarters, revenue has moved from US$17.7 million and EPS of US$0.70 in Q2 2025 to US$22.2 million and EPS of US$0.94 in Q4 2025, and then to US$23.2 million and EPS of US$1.04 in the latest quarter, setting up this report against a...

Orrstown Financial Services (ORRF) has put up another solid quarter on the numbers, with Q2 2026 revenue of US$62.3 million, basic EPS of US$1.10 and trailing twelve month EPS of US$4.48 framing the latest performance. The company has seen revenue move from US$62.3 million in Q2 2025 to US$62.3 million in Q2 2026 on a quarterly basis, while trailing twelve month revenue sits at US$255.4 million, setting the backdrop for a year in which reported earnings growth over the last 12 months was...

BankUnited (BKU) opened Q2 2026 with total revenue of US$269.0 million and basic EPS of US$0.97, setting the tone for a quarter where profitability stayed firmly in focus. Over the last few quarters, the company has seen revenue move from US$258.2 million in Q2 2025 to US$269.0 million in Q2 2026, while quarterly EPS has ranged between US$0.78 and just under US$0.99. This gives investors a clearer view of earnings power ahead of this latest print. With trailing 12 month net profit margins...

Triumph Financial (TFIN) has put up a solid Q2 2026 print, with revenue at US$117.5 million and basic EPS of US$0.44 on net income of US$10.6 million, backed by a trailing twelve month EPS of US$1.49. The company has seen revenue move from US$108.8 million in Q2 2025 to US$117.5 million in Q2 2026, while quarterly EPS has shifted from US$0.15 to US$0.44. This sets the stage for investors to focus on how the 7.9% trailing net profit margin and 6.15% net interest margin shape the quality of...

AT&T (T) has reported Q2 2026 revenue of US$31.6 billion and basic EPS of US$0.67, with net income from continuing operations of US$4.6 billion setting the tone for its latest results. The company has seen quarterly revenue move between US$30.6 billion and US$33.5 billion over the past six reporting periods, while basic EPS has ranged from US$0.53 to US$1.30, giving investors a clear view of how the top line and per share earnings have tracked through recent quarters. With a trailing 12 month...

After a 58.8% gain over the past five years, Charles Schwab stock is no longer an obvious bargain at first glance. However, the intrinsic value estimate from the Excess Returns model still points to meaningful upside relative to the current US$100.8 share price. That sets up a clear tension for investors weighing the recent performance against what the valuation checks are implying today. Over five years, Charles Schwab has returned 58.8%. This means anyone looking at the stock now is...

TE Connectivity (TEL) has just reported Q3 2026 revenue of US$5.2b and basic EPS of US$2.57, with the trailing twelve months showing revenue of US$19.3b and EPS of US$10.29 alongside reported earnings growth of 107.5% over the past year. The company has seen revenue move from US$17.3b to US$19.3b on a trailing basis, while net income excluding extra items increased from US$1.8b to US$3.0b, supported by an improvement in net profit margin to 15.6% from 8.8%. For investors, that margin profile...

On July 20, 2026, Agnico Eagle Mines Limited was added to the Zacks Rank #5 (Strong Sell) list after Zacks cut its consensus earnings estimate for the current year by 6.5% over the prior 60 days. This downgrade signals that analysts recently reduced their expectations for Agnico Eagle’s financial performance, raising questions about how resilient its existing growth plans may be. We’ll now examine how the Zacks downgrade and lowered earnings expectations may reshape Agnico Eagle’s previously...